Cargando…

Subsequent Immunization of Pigs with African Swine Fever Virus (ASFV) Seroimmunotype IV Vaccine Strain FK-32/135 and by Recombinant Plasmid DNA Containing the CD2v Derived from MK-200 ASFV Seroimmunotype III Strain Does Not Protect from Challenge with ASFV Seroimmunotype III

Understanding the immunological mechanisms of protection and the viral proteins involved in the induction of a protective immune response to the African swine fever virus (ASFV) is still limited. In the last years, the CD2v protein (gp110-140) of the ASFV has been proven to be a serotype-specific pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sereda, Alexey D., Kazakova, Anna S., Namsrayn, Sanzhi G., Vlasov, Mikhail E., Sindryakova, Irina P., Kolbasov, Denis V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221915/
https://www.ncbi.nlm.nih.gov/pubmed/37243111
http://dx.doi.org/10.3390/vaccines11051007
_version_ 1785049570759147520
author Sereda, Alexey D.
Kazakova, Anna S.
Namsrayn, Sanzhi G.
Vlasov, Mikhail E.
Sindryakova, Irina P.
Kolbasov, Denis V.
author_facet Sereda, Alexey D.
Kazakova, Anna S.
Namsrayn, Sanzhi G.
Vlasov, Mikhail E.
Sindryakova, Irina P.
Kolbasov, Denis V.
author_sort Sereda, Alexey D.
collection PubMed
description Understanding the immunological mechanisms of protection and the viral proteins involved in the induction of a protective immune response to the African swine fever virus (ASFV) is still limited. In the last years, the CD2v protein (gp110-140) of the ASFV has been proven to be a serotype-specific protein. Current work is devoted to the investigation of the possibility of creating protection against virulent ASFV strain Mozambique-78 (seroimmunotype III) in pigs previously vaccinated with vaccine strain FK-32/135 (seroimmunotype IV) and then immunized with the pUBB76A_CD2v plasmid, containing a chimeric nucleotide sequence from the CD2v protein gene (EP402R, nucleotides from 49 to 651) from the MK-200 strain (seroimmunotype III). Vaccination with the ASFV vaccine strain FK-32/135 protects pigs from the disease caused by the strain with homologous seroimmunotype—France-32 (seroimmunotype IV). Our attempt to create balanced protection against virulent strain Mozambique-78 (seroimmunotype III) by induction of both humoral factors of immunity (by vaccination with strain FK-32/135 of seroimmunotype IV) and serotype-specific cellular immunity (by immunization with the plasmid pUBB76A_CD2v of seroimmunotype III) was unsuccessful.
format Online
Article
Text
id pubmed-10221915
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102219152023-05-28 Subsequent Immunization of Pigs with African Swine Fever Virus (ASFV) Seroimmunotype IV Vaccine Strain FK-32/135 and by Recombinant Plasmid DNA Containing the CD2v Derived from MK-200 ASFV Seroimmunotype III Strain Does Not Protect from Challenge with ASFV Seroimmunotype III Sereda, Alexey D. Kazakova, Anna S. Namsrayn, Sanzhi G. Vlasov, Mikhail E. Sindryakova, Irina P. Kolbasov, Denis V. Vaccines (Basel) Article Understanding the immunological mechanisms of protection and the viral proteins involved in the induction of a protective immune response to the African swine fever virus (ASFV) is still limited. In the last years, the CD2v protein (gp110-140) of the ASFV has been proven to be a serotype-specific protein. Current work is devoted to the investigation of the possibility of creating protection against virulent ASFV strain Mozambique-78 (seroimmunotype III) in pigs previously vaccinated with vaccine strain FK-32/135 (seroimmunotype IV) and then immunized with the pUBB76A_CD2v plasmid, containing a chimeric nucleotide sequence from the CD2v protein gene (EP402R, nucleotides from 49 to 651) from the MK-200 strain (seroimmunotype III). Vaccination with the ASFV vaccine strain FK-32/135 protects pigs from the disease caused by the strain with homologous seroimmunotype—France-32 (seroimmunotype IV). Our attempt to create balanced protection against virulent strain Mozambique-78 (seroimmunotype III) by induction of both humoral factors of immunity (by vaccination with strain FK-32/135 of seroimmunotype IV) and serotype-specific cellular immunity (by immunization with the plasmid pUBB76A_CD2v of seroimmunotype III) was unsuccessful. MDPI 2023-05-21 /pmc/articles/PMC10221915/ /pubmed/37243111 http://dx.doi.org/10.3390/vaccines11051007 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sereda, Alexey D.
Kazakova, Anna S.
Namsrayn, Sanzhi G.
Vlasov, Mikhail E.
Sindryakova, Irina P.
Kolbasov, Denis V.
Subsequent Immunization of Pigs with African Swine Fever Virus (ASFV) Seroimmunotype IV Vaccine Strain FK-32/135 and by Recombinant Plasmid DNA Containing the CD2v Derived from MK-200 ASFV Seroimmunotype III Strain Does Not Protect from Challenge with ASFV Seroimmunotype III
title Subsequent Immunization of Pigs with African Swine Fever Virus (ASFV) Seroimmunotype IV Vaccine Strain FK-32/135 and by Recombinant Plasmid DNA Containing the CD2v Derived from MK-200 ASFV Seroimmunotype III Strain Does Not Protect from Challenge with ASFV Seroimmunotype III
title_full Subsequent Immunization of Pigs with African Swine Fever Virus (ASFV) Seroimmunotype IV Vaccine Strain FK-32/135 and by Recombinant Plasmid DNA Containing the CD2v Derived from MK-200 ASFV Seroimmunotype III Strain Does Not Protect from Challenge with ASFV Seroimmunotype III
title_fullStr Subsequent Immunization of Pigs with African Swine Fever Virus (ASFV) Seroimmunotype IV Vaccine Strain FK-32/135 and by Recombinant Plasmid DNA Containing the CD2v Derived from MK-200 ASFV Seroimmunotype III Strain Does Not Protect from Challenge with ASFV Seroimmunotype III
title_full_unstemmed Subsequent Immunization of Pigs with African Swine Fever Virus (ASFV) Seroimmunotype IV Vaccine Strain FK-32/135 and by Recombinant Plasmid DNA Containing the CD2v Derived from MK-200 ASFV Seroimmunotype III Strain Does Not Protect from Challenge with ASFV Seroimmunotype III
title_short Subsequent Immunization of Pigs with African Swine Fever Virus (ASFV) Seroimmunotype IV Vaccine Strain FK-32/135 and by Recombinant Plasmid DNA Containing the CD2v Derived from MK-200 ASFV Seroimmunotype III Strain Does Not Protect from Challenge with ASFV Seroimmunotype III
title_sort subsequent immunization of pigs with african swine fever virus (asfv) seroimmunotype iv vaccine strain fk-32/135 and by recombinant plasmid dna containing the cd2v derived from mk-200 asfv seroimmunotype iii strain does not protect from challenge with asfv seroimmunotype iii
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221915/
https://www.ncbi.nlm.nih.gov/pubmed/37243111
http://dx.doi.org/10.3390/vaccines11051007
work_keys_str_mv AT seredaalexeyd subsequentimmunizationofpigswithafricanswinefevervirusasfvseroimmunotypeivvaccinestrainfk32135andbyrecombinantplasmiddnacontainingthecd2vderivedfrommk200asfvseroimmunotypeiiistraindoesnotprotectfromchallengewithasfvseroimmunotypeiii
AT kazakovaannas subsequentimmunizationofpigswithafricanswinefevervirusasfvseroimmunotypeivvaccinestrainfk32135andbyrecombinantplasmiddnacontainingthecd2vderivedfrommk200asfvseroimmunotypeiiistraindoesnotprotectfromchallengewithasfvseroimmunotypeiii
AT namsraynsanzhig subsequentimmunizationofpigswithafricanswinefevervirusasfvseroimmunotypeivvaccinestrainfk32135andbyrecombinantplasmiddnacontainingthecd2vderivedfrommk200asfvseroimmunotypeiiistraindoesnotprotectfromchallengewithasfvseroimmunotypeiii
AT vlasovmikhaile subsequentimmunizationofpigswithafricanswinefevervirusasfvseroimmunotypeivvaccinestrainfk32135andbyrecombinantplasmiddnacontainingthecd2vderivedfrommk200asfvseroimmunotypeiiistraindoesnotprotectfromchallengewithasfvseroimmunotypeiii
AT sindryakovairinap subsequentimmunizationofpigswithafricanswinefevervirusasfvseroimmunotypeivvaccinestrainfk32135andbyrecombinantplasmiddnacontainingthecd2vderivedfrommk200asfvseroimmunotypeiiistraindoesnotprotectfromchallengewithasfvseroimmunotypeiii
AT kolbasovdenisv subsequentimmunizationofpigswithafricanswinefevervirusasfvseroimmunotypeivvaccinestrainfk32135andbyrecombinantplasmiddnacontainingthecd2vderivedfrommk200asfvseroimmunotypeiiistraindoesnotprotectfromchallengewithasfvseroimmunotypeiii